NCT05023031

Evaluation of Pharmacokinetic and Safety of NVP-2102 and NVP-2102-R in Healthy Subjects

A Phase 1 Clinical Trial, Open-label, Randomized Study in Healthy Subjects to Evaluate Pharmacokinetic Characteristics and Safety After Oral Administration of NVP-2102 and NVP-2102-R in Healthy Subjects

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 53 (actual)
• Sponsor: NVP Healthcare · Industry
• Sex: All
• Age: 19 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to compare the pharmacokinetics and safety of NVP-2102 and NVP-2102-R.

Detailed description

Evaluate the pharmacokinetics and safety of NVP-2102 compared to NVP-2102-R

Conditions

• Healthy Subjects

Interventions

Type	Name	Description
DRUG	NVP-2102	Tablet formulation for oral administration, single dose of NVP-2102 at Day 1
DRUG	NVP-2102-R	Tablet formulation for oral administration, single dose of NVP-2102-R at Day 1

Timeline

• Start date: 2021-10-05
• Primary completion: 2021-12-24
• Completion: 2022-01-15
• First posted: 2021-08-26
• Last updated: 2022-01-19

Locations

1 site across 1 country: South Korea